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Abstract
LMP1-mediated activation of nuclear factor of kappaB (NF-kB) is critical for the ligand independent proliferation and cell
survival of in vitro EBV-transformed lymphoblastoid cell lines (LCLs). Previous experiments revealed that a majority of LMP1-
dependent responses are regulated by NF-kB. However, the extent that individual NF-kB family members are required for
these responses, in particular, c-Rel, whose expression is restricted to mature hematopoietic cells, remains unclear. Here we
report that low c-Rel expression in LCLs derived from a patient with hyper-IgM syndrome (Pt1), resulted in defects in
proliferation and cell survival. In contrast to studies that associated loss of NF-kB with increased apoptosis, Pt1 LCLs failed to
initiate apoptosis and alternatively underwent autophagy and necrotic cell death. Whereas the proliferation defect
appeared linked to a c-Rel-associated decrease in c-myc expression, identified pro-survival and pro-apoptotic targets were
expressed at or near control levels consistent with the absence of apoptosis. Ultrastructural examination of Pt1 LCLs
revealed a high level of cellular and ER stress that was further supported by gene expression profiling showing the
upregulation of several genes involved in stress and inflammation. Apoptosis-independent cell death was accompanied by
increased expression of the inflammatory marker, caspase-4. Using gene overexpression and siRNA knockdown we
demonstrated that levels of c-Rel directly modulated expression of caspase-4 as well as other ER stress genes. Overall, these
findings reveal the importance of c-Rel in maintaining LCL viability and that decreased expression results in ER stress and a
default response leading to necrotic cell death.
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Introduction
Constitutive activation of the Rel/NF-kB signal transduction
pathway has been associated with a wide range of malignancies in
both animals and humans and thus has long constituted a favored
target for potential therapeutic intervention [1]. Among the
multiple Rel/NF-kB family members, only c-Rel, the cellular
counterpart of v-Rel, whose expression leads to aggressive
lymphomas in chickens [2], has demonstrated the capacity to
malignantly transform cells in culture [3,4]. Accordingly, gene
amplification or persistent activation of c-Rel is detected in many
human B cell tumors including diffuse large B cell lymphoma
(DLBCL), Hodgkin’s lymphoma, follicular B cell lymphoma and
mediastinal large B-cell lymphoma [5,6,7,8]. Recent results using
siRNA gene silencing found that downregulating c-Rel in a B cell
tumor line resulted in a marked increase in apoptotic cell death
highlighting the potential for c-Rel as a therapeutic target [9].
Although c-Rel is expressed predominantly in mature lymphoid
and myeloid tissues its expression and function has been most fully
characterized in B cells where it is required for both antigen-
dependent differentiation and late-stage effector functions
[10,11,12,13]. Targeted deletion of c-rel in B cells elicited primary
defects in mitogen- and antigen-induced proliferation as well as a
significant loss of antibody production in antigen-responding cells
[14,15]. The proliferative defect was effectively complemented by
over-expression of cyclin E, which is induced by the c-Rel-
mediated transcription factor E2F3a as well as by Bcl-xL [16,17].
In addition to proliferative defects, c-rel-deficient B cells were
highly sensitized to apoptosis through pathways activated by
antigen receptor engagement, gamma-irradiation and dexameth-
asone treatment [18,19,20,21]. In B cells, c-Rel is expressed in
response to BCR, CD40 and BAFF-R (BR3) signaling and known
regulators include PI3 kinase/Akt [18,22,23,24], Bcl-10 [25],
Carma-1 [26,27], and isoforms of protein kinase C [28]. These
signals result in c-Rel expression through autoregulation and by
the activation of transcription factors SpiB and PU.1 that bind to
specific sites in the c-Rel promoter (reviewed in [29]).
Our interest in the relationship of c-Rel expression to B cell
function extends from our characterization of a patient with non-
X-linked hyper-IgM syndrome (Pt1), in which primary B cells were
impaired in activation due to delayed responses to CD40 signals
[30]. This defect resulted in a lack of class switched antibodies
with an attendant increase in infections. In vitro class switch
recombination was restored if B cells received sustained signaling
through CD40L expressed on 293 cells but not by activated CD4
+
T cells. To recapitulate continuous CD40 signaling and determine
whether the defect could be rescued and further analyzed, B cells
were infected with Epstein Barr virus (EBV) and lymphoblastoid
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phenotype in the context of sustained signals through the CD40
viral mimic, latent membrane protein (LMP)1. We found that the
Pt1-LCLs and -LCL
tet cells (cells transformed with a mini-EBV
vector expressing LMP1 from a tetracycline-inducible promoter
[31]) failed to proliferate in response to CD40 signals however,
there was growth in response to LMP1. Importantly, the Pt1-
LCL
tet cells retained a subset of characteristics found in the
primary B cells including reduced levels of surface CD23. These
defects were not complemented by LMP1 and were directly linked
to decreased c-Rel expression [32].
In this study, we have used the Pt1-LCL
tet cells to ask questions
regarding cell proliferation and survival in EBV-transformed B
cells that constitutively express low levels of c-Rel. Importantly, we
found that proliferation and survival were impaired in these cells
even in the context of continuous LMP1 expression. However, cell
death was caspase-independent and highly consistent with
autophagy followed by necrotic cell death. Additionally, ultra-
structural imaging and gene expression profiling revealed that cells
displayed a high degree of metabolic stress that was characterized
by changes in the endoplasmic reticulum (ER) and the expression
of inflammatory mediators. Notably, c-Rel was shown to be a
negative regulator of caspase-4, a member of the inflammatory
family of caspases involved in the regulation of the ER stress
response, autophagy and cell survival. These results indicate that
Pt1 cells experience a high degree of cellular stress that is linked to
low c-Rel expression, reduced proliferation, and increased cell
death. These findings provide important insights into the Pt1
defect and how EBV transformation may moderate the effect of
low c-Rel expression on the viability of malignant B cells.
Results
Low c-Rel results in decreased c-myc expression
Our previous analysis of c-Rel expression in Pt1 and control
cells suggested that reduced c-Rel expression was due to
translational or post-translational differences [32]. However,
additional analyses using multiple primer pairs that targeted both
the 59 and 39untranslated regions revealed that reduced c-Rel
corresponded to a transcriptional defect that resulted in an
approximate 3.5-fold decrease in RNA (Figure 1A). Examination
of NF-kB subunit expression in Pt1 cells confirmed that c-Rel was
selectively decreased and that all other Rel/NF-kB family
members were expressed at control levels (Figure 1B). We also
assayed the expression of proteins involved in cell survival and
proliferation, which are known to be direct or indirect targets of c-
Rel [29,33]. As shown in Figures 1C and 1D, no consistent
differences were detected in Bcl-2 and Mcl-1 expression between
Pt1 and control cells whereas Bcl-xL was found to be slightly
lower. In contrast c-myc expression at both the protein and RNA
levels was clearly reduced, suggesting defects in cell survival and
proliferation.
The Pt1 cells have defects in proliferation
To assess the degree that low c-Rel affected cell growth, cells
were spun through a ficoll gradient to remove dead or dying cells
from the population and 4610
6 viable cells were cultured in media
containing tetracycline (Tc) to maintain LMP1 expression. While
cultures of both Pt1 and control cells doubled during the initial
24 h period, only the control population continued to expand
beyond this point (Figure 2A). The extent that the stationary phase
reflected a proliferation defect was analyzed by monitoring CFSE
incorporation in cells removed from Tc media for 5 days and re-
plated in Tc media or media supplemented with soluble CD40
ligand (sCD40L) for 4 and 6 days. As expected, both control
populations proliferated in response to LMP1 and sCD40L by day
4 and continued to do so through day 6 (Figure 2B, middle and
right graphs). In contrast, the Pt1 population expressing LMP1
divided only after four days while no proliferation was detected at
day six, whereas the cells stimulated with sCD40L showed little to
no proliferation at either time point (upper and lower left graphs).
Decreased proliferation was further confirmed by analyzing the
phosphorylation level of CDC2, a protein that is functional during
the G2/M checkpoint of the cell cycle. We observed that the mean
fluorescence intensity (MFI) of the phosphorylated inactive form
was approximately 2-fold greater in the Pt1 cells compared to
D11 control cells indicating less cycling by the Pt1 population
(Figure 2C).
Cell death is occurring through a caspase-independent
mechanism
Deletion of c-myc in activated primary B cells results in a severe
loss of proliferative capacity [34] whereas down regulation of c-
myc in several tumor lines results in both loss of proliferation and
increased in cell death [35,36,37,38]. Based on these observations
and on our finding that c-Myc is down regulated in the Pt1 cells,
we analyzed cells by Annexin V and propidium iodide (PI) staining
for evidence of early- (Annexin V
+,P I
2) and late-stage (Annexin
V
+,P I
+) cell death. We found that induction of LMP1 expression
in the Pt1 cells resulted in an approximate 2-fold increase in the
Annexin V positive population over cells cultured without LMP1.
However, in agreement with the lack of proliferation in response
to CD40, there was no significant increase in cell death upon
stimulation with sCD40L (Figure 3A, upper panels). In contrast,
the level of ongoing cell death in the control population was
approximately 3-fold lower under all conditions (lower panels)
suggesting that the Pt1 cells were more susceptible to cell death
independent of CD40 or LMP1 signals.
To determine whether cell death was occurring through
apoptosis, a broad-spectrum caspase inhibitor, Q-VD-OPh was
added to Pt1 cells that had been cultured for several days in the
presence of Tc media and proliferating at a very limited rate (see
Figure 2A). Surprisingly, 24 h after addition of the inhibitor there
was little to no change in the overall percentage of Annexin V
positive cells suggesting that caspase activity was unlinked to cell
death (Figure 3B). Additional hallmarks of apoptosis, including
both PARP and caspase-3 cleavage, as well as increased expression
of pro-apoptotic proteins Bax and Bad, were absent in Pt1 and
control cells following growth with or without LMP1 (Figure S1).
However, when the overall level of caspase activity was measured
using sulforhodamine-FLICA, a fluorescent cell-permeable inhib-
itor that reacts with the active site of all caspases [39], it was clear
that caspase activity was unusually high in Pt1 cells (Figure 3C).
These findings indicated that the high level of caspase activity and
poor viability of the Pt1 cells appeared linked to cell death
exclusive of apoptosis.
Pt1-LCL
tet cells display morphological characteristics of
cellular stress
We next questioned whether autophagy was initiated in Pt1 cells
as a pathway to enhance survival since it has been previously
shown that under conditions of stress, cells defective in apoptosis
will often activate autophagy as a cell survival mechanism [40,41].
We initially assayed the increase in LC3-II expression, the
lipodated product of LC3-I that is a marker for autophagy
[42,43] and found that Pt1 cells expressed a higher level of LC3-II
relative to control cells under all conditions of culture (Figure 4A).
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Methyladenine (3-MA), that effectively prevents autophagosome
formation, approximately a 3-fold increase in necrotic cell death
(Annexin V
+PI
+) was detected with no significant change in early
cell death (Annexin V
+PI
2) (Figure 4B). We interpret these
findings to suggest that autophagy is an ongoing process in the Pt1
cells that occurs in the presence or absence of signals through
CD40 or LMP1. Also, inhibition of autophagy results in a higher
number of cells being rapidly shunted into a pathway leading to
necrotic cell death.
To extend these findings and identify structural indications of
autophagy, Transmission Electron Microscopy (TEM) was carried
out using Pt1 and control D11 cells grown in Tc media for greater
than 7 days (with LMP1 signaling). Autophagosomes were clearly
present in the cytoplasm of Pt1 cells in a number of images
(Figure 4C, see closed arrows). However, the number was more
limited than expected and the more striking picture was one of
extensive cellular stress and cell death (upper and middle panels).
Specifically, the majority of cells contained a high number of
translucent vacuoles in the cytoplasm that were consistent with
endoplasmic reticulum (ER) dilations (see open triangles). In
addition, there were many fewer mitochondria compared to
control cells and a number of Pt1 cells displayed distortions in the
nuclear membrane and electron-dense material in the nuclei (see
asterisks). These images were in clear contrast to the control cells
that displayed no outward signs of cellular stress or autophagy
(lower panel). Together, these results are consistent with c-Rel-
dependent defects in growth and proliferation resulting in an
increased level of cellular and/or ER stress. Under these
conditions autophagy appears to be activated as a survival strategy
but is insufficient over time to compensate for the initiating stress
and as a consequence cell death occurs through an apoptosis-
independent pathway.
Genes involved in ER and metabolic stress are activated
in Pt1 cells
To understand how c-Rel may play a role in the phenotypic
changes observed in the Pt1 cells we utilized microarray analysis to
identify targets that were either co-modulated with c-Rel or
Figure 1. Decreased c-Rel in Pt1 cells is consistent with low c-Myc expression. (A) Relative amounts of c-Rel mRNA determined by
quantitative real-time PCR (qRT-PCR) using three distinct sets of primers and cDNA generated from Pt1-, D11- and C2-LCL
tet cells. Set #1 (used in Lu,
et. al. [32]), Set #2 (targeting the 39 UTR) and Set #3 (targeting the 59UTR). Numbers shown are the average and SEM from three independent
experiments (** indicates a p,0.01). (B)3 0mg of total cell extract prepared from Pt1 and control (C2 and D11) cells grown in the presence of Tc were
analyzed by immunoblotting for expression of NF-kB family members c-Rel, p50, p52, p65 and RelB. Actin is shown as a loading control. (C) Western
Blot analysis showing the levels of pro-survival genes Bcl-2, Bcl-XL and Mcl-1 as well as c-Myc in 30 mg of total cell extract prepared from Pt1- and
control C2- and D11 -LCL
tet cells. Actin is shown as a loading control. (D) Analysis of c-myc expression using cDNA generated from RNA isolated from
Pt1- and control D11-LCL
tet cells grown in Tc media and qRT-PCR. Numbers shown are the average and SEM of three independent experiments
(** indicates a p,0.01).
doi:10.1371/journal.pone.0025467.g001
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stress pathways. We assessed gene expression differences in the Pt1
cells following continuous growth in Tc media (greater than 7
days) against two control lines that showed differences in Ig
expression and growth characteristics in order to highlight
differences that were beyond normal phenotypic variation of
immortalized LCLs [44,45]. Of the 27,000 genes assessed, 764
(p=0.05) displayed differential expression of 1.6-fold or higher.
Importantly, we were able to show that both the expression of c-
Rel and CD23 (FCER2), which had been previously identified as a
bona fide c-Rel target, were decreased on the array [32]. However,
there was no difference in the expression of pro-survival genes
including Bcl-xL and thus the difference observed at the protein
level was likely independent of a direct, c-Rel-specific affect on
transcription (see Figure 1C). In contrast, a number of c-Rel
regulated genes with roles in transcriptional regulation, cell
structure, signaling and motility were found to be downregulated.
In contrast, several other genes both related to c-Rel and the
inflammatory response were upregulated compared to controls
(Table 1).
In analyzing the overall changes in the Pt1 transcriptome we
confirmed that a number of genes that mapped to metabolic/ER
stress and autophagy pathways were differentially expressed
(Table 2). Specifically, there was an increase in several heat shock
genes as well as XBP1, a regulatory factor involved in ER stress.
Ingenuity Pathway Analysis (IPA) was performed and pathways
involving cell structure, motility and inflammation were found to
be significantly different (data not shown). We were particularly
interested in the changes relating to inflammation, which included
highly expressed MMP7, IL-1b, IL-1bR, STAT3, TNFR, Cox-2
and others (Table 2). These data suggested that ongoing cell death
and reduced proliferation were linked to autophagy, ER stress and
a heightened inflammatory response in the Pt1 cells.
Caspase-4 is upregulated in Pt1 cells
In support of our biochemical studies, we failed to observed
transcriptional changes in factors relating either to the intrinsic or
extrinsic apoptotic pathways (data not shown). However, we did
note an increase in the expression of caspase-4 an ER-resident
inflammatory caspase, which is a member of the interleukin-1b-
coverting enzyme subfamily (reviewed in [46]). The expression of
caspase-4 is modulated by interferons and induced in response to
ER stress although few downstream target genes have been
identified [47,48,49]. To determine whether caspase-4 was
responsible for the increase in caspase activity present in Pt1 cells,
we first confirmed that it was upregulated at the RNA level by
qRT-PCR (Figure 5A). Additionally, intracellular staining re-
vealed a higher level of total caspase-4 expression in Pt1 cells
compared to control D11 cells (Figure 5B) and this increase was
confirmed by Western blotting that showed a marked increase
both in the pro and active forms of caspase-4 (Figure 5C). To rule
out the possibility that the overall increase in caspase activity
reflected an increase in the active forms of effector caspases, cells
were incubated with a fluorescent competitor that binds
specifically to the active sites of caspases-3 and -7 and no
difference in binding was observed between control D11 and Pt1
cells (Figure 5D). Selective elevation of caspase-1 activity in Pt1
cells was similarly ruled out (data not shown). Thus, the absence of
an increase in the active forms of caspases-3 and -7 as well as
caspase-1 is highly consistent with the elevated caspase activity in
Pt1 cells being an outcome of increased caspase-4 activation.
Caspase-4 is regulated by c-Rel
To establish whether low c-Rel was responsible for elevated
caspase-4 activity we used transient transfection to increase c-Rel
levels in Pt1 cells. However, due to the fragile state of the Pt1
population very few viable cells remained after transfection
making biochemical analysis impossible. Expression was thus
assessed using intracellular staining and gating on the viable
population. In multiple experiments we observed a marked
decrease in caspase-4 specifically in the c-Rel transfected
population confirming a role for c-Rel as a negative regulator of
Figure 2. Pt1 cells have reduced proliferation in response to
CD40 or LMP1 signaling. (A) Pt1- (dashed line) and control D11-
LCL
tet cells (solid line) grown in the absence of Tc for 5 days were plated
at 1610
6 cells/mL in Tc media and cultured in parallel for 6 days. Cells
were withdrawn at days 1, 3 and 6 cells and counted using Trypan-Blue
exclusion to determine the total number of viable cells. (B)1 610
6 Pt1-
and control D11- and C2-LCL
tet cells were stained with CFSE and
cultured in Tc media (pink line), absence of Tc (for 5 days prior to CFSE
staining) (grey peak) or absence of Tc plus sCD40L (500 ng/mL) (green
line) for 6 days. At day 4 (upper panel) and day 6 (lower panel) cells
were analyzed for proliferation by flow cytometry. (C) Pt1- and control
D11-LCL
tet cells (2610
5) grown in Tc media were analyzed for the
expression of phosphorylated-CDC2 by intra-cellular staining. Numbers
shown are the mean fluorescence intensity (MFI) of cells expressing
high levels of phosphorylated CDC2. Graph is representative of three
independent experiments.
doi:10.1371/journal.pone.0025467.g002
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regulating c-Rel would result in an increase in caspase-4
expression in control cells. Control D11 cells were transfected
with siRNA against c-Rel (siRel) or against a control sequence
(siCTRL) and 48 h post-transfection caspase-4 expression was
monitored using intracellular staining. The results of multiple
transfections revealed a reproducible increase in caspase-4
expression in cells transfected with siRel (Figure 6B). The
difference in the overall change relatively to the over-expression
studies is most likely a consequence of the degree of downregu-
lation of c-Rel protein, which was approximately 50% of wildtype
levels (data not shown).
To extend these findings and ask whether increasing c-Rel
would have an effect on the expression of genes involved in ER
stress, we analyzed two heat shock proteins, HspA6 and HspA7,
whose expression was upregulated on the microarray and further
confirmed by real time PCR (Figure 6C). To this end, RNA was
isolated from Pt1 cells 48 h after transfection with either the c-Rel-
expressing plasmid or empty vector. We found that the levels
of caspase-4, HspA6, and HspA7 RNA were significantly
down regulated following transient expression of c-Rel. Also, we
observed a small, but reproducible increase in c-myc expression
(Figure 6D). Thus, the expression of c-Rel is linked to the rapid
modulation of genes relating to both cell cycle regulation and ER
stress.
Discussion
In this report we demonstrate that low c-Rel expression in an
EBV-transformed B cell line is coincident with decreased
proliferation and reduced cell survival. However, unlike previous
work showing that decreased NF-kB levels in EBV transformed
LCLs leads to apoptosis [50,51], our findings suggest that EBV
modulates cellular responses to low c-Rel by decreasing viability
through a process dependent on autophagy and necrotic cell
death. Whereas we found that viable Pt1-LCL
tet cells respond to
LMP1 signals and proliferate at wildtype levels for approximately
24 h, beyond this initial time frame, these low c-Rel-expressing
cells undergo cell death at a higher rate than cells not receiving
proliferative signals. This data suggested that proliferation and cell
death are intricately linked and most likely reflect the fact that the
cells are becoming increasingly metabolically stressed. Although
Figure 3. Increased cell death in the Pt1 cells is independent of caspase activity. (A) Analysis of cell viability in Pt1 and control populations
grown in Tc media, absence of Tc (5 days) or absence of Tc+sCD40L (500 ng/mL) (24 h). 2610
5 cells were stained with Annexin-V and Propidium
Iodide (PI) and analyzed by flow cytometry. Numbers shown are the percentage of Anexin-V
+/PI
2 cells (early cell death) plus Anexin-V
+/PI
+ (necrotic/
late cell death). (B)2 610
5 Pt1 cells grown in Tc media were analyzed for cell death by flow cytometry 24 h post-treatment with 5 mM Q-VD-OPh.
Numbers shown are the percentage of Anexin-V
+/PI
2 cells (early cell death) and Anexin-V
+/PI
+ (necrotic/late cell death). (C) Analysis of total levels of
active caspases in Pt1 and control D11 cells grown in Tc media, absence of Tc (5 days) or absence of Tc+500 ng/ml sCD40L for 24 h. 2610
5 cells were
incubated at 37uC for 2 h with polycaspase red-FLICA and analyzed by flow cytometry. Numbers shown are the average and SEM from three
independent experiments.
doi:10.1371/journal.pone.0025467.g003
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[9,14,15] B cells heterozygous for c-rel retained proliferative
potential that was intermediate to wildtype and homozygous
deleted cells suggesting that overall gene dosage is important for
optimal c-Rel function [15]. In this regard, a low level of
proliferation in Pt1 cells is consistent with c-Rel expression being
low but not completely absent.
Our results showing that the Pt1 cells fail to undergo apoptosis
in response to low c-Rel is highly distinct from previous
experiments that reported increased growth arrest and apoptosis
in LCLs with inhibited NF-kB activity [50,51]. One study found
that cell death lacked some of the hallmarks of programmed cell
death [51] and although similar to our findings, the complete
absence of an apoptotic signature in our work may reflect the fact
that Pt1 cells have only a c-Rel deficiency and retain normal
expression of the other NF-kB family members. Regulatory signals
from these proteins may modulate the expression of pro-survival
Bcl-2 family members by successfully preventing the induction of
effector caspases (reviewed in [52]). It is interesting that CD40
signals were found to rescue mouse c-rel deficient B cells from
apoptosis [15] and in our system the signals coming from LMP1
appear capable of substituting for this function. Notably,
transcriptional profiling of B cells expressing an inducible LMP1
protein confirmed that a number of pro-survival genes are
transcribed within 15 min of LMP1 expression [53,54]. Our
results demonstrate that reduced levels of c-Rel within the context
of EBV transformation appear not to noticeably alter levels of
known pro-survival targets of LMP1 (even though pro-apoptotic
proteins, Bax and Bad are high) and this may in fact underlie the
absence of apoptotic cell death. Thus, EBV infection appears to
rescue cell death mediated by reduced levels of c-Rel but not
c-Rel-dependent proliferation that is tightly associated with
decreased levels of c-Myc.
Figure 4. Pt1 cells display characteristic features of autophagy,
ER-stress and necrosis. (A) LC3 expression in Pt1 and control (D11
and C2) cells. 30 mg of total cell extract isolated from Pt1 and control
cells grown in Tc media, in the absence of Tc (5 days) or absence of Tc
plus sCD40L (500 ng/mL) for 24 h was analyzed by immunoblotting
using anti-LC3 antibodies. The Pt1 lanes are delineated with a red box
to highlight the presence of LC3-II. Total cell extract (6 mg/mL) prepared
from anti-IgM stimulated Ramos cells is shown as a positive control for
LC3-II expression and actin is shown as a loading control. (B)2 610
5 Pt1-
LCL
tet cells grown in Tc media were treated with 10 mM of the
autophagy inhibitor 3-MA (right panel) or DMSO (left panel), stained
with Annexin-V and Propidium Iodide (PI) and analyzed by flow
cytometry. (C) Pt1- (upper and middle panels) and control D11-LCL
tet
cells (lower panel) grown in Tc media were analyzed by transmission
electron microscopy. Areas of high electron density (asterisks), dilations
of the ER (open triangles) or autophagosomes (arrows) are observed
only in the Pt1 cells and not in the control cells. Images in the middle
panels are magnifications of the selected area (open square) shown on
upper panel.
doi:10.1371/journal.pone.0025467.g004
Table 1. c-Rel-associated genes.
Gene name Function
Fold
change
1
Relationship
to c-Rel
FOXO3 Transcription factor Q3.2 Transcriptional target
EGR2 Transcription factor Q3.7 ’’
PPPIR15-A Phosphatase Q2.2 ’’
VIM matrix protein Q4.4 ’’
FCER2 (CD23) Surface receptor Q2.5 ’’
Myc Cell-cycle regulator Q2.1 ’’
IL1B Inflammatory cytokine q7.9 ’’
CXCL10 Chemokine q5.7 ’’
TNFSF13C Surface receptor q1.6 ’’
Bcl-xL Pro-survival N.C. ’’
Mcl-1 Pro-survival N.C. ’’
Bfl-1/A1 Pro-survival N.C. ’’
IL1A Inflammatory cytokine Q2.9 c-Rel Nuclear
translocation
HSPA1A Protein folding q2.2 Protein-protein
interaction
HSPA6 Protein folding q2.3 ’’
1Arrows indicate the fold change difference in comparing the average
expression of Pt1 genes (two duplicate samples) to duplicate arrays of two
different control lymphoblastoid cell lines (four samples total). N.C. indicates
‘‘no change’’.
doi:10.1371/journal.pone.0025467.t001
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activity and ER stress is closely linked to c-Rel expression.
Whereas our understanding of caspase-4 regulation and potential
downstream targets is still evolving, caspase-4 and its putative
mouse homolog caspase-12 have been reported to directly connect
ER stress to apoptosis. Activation of these inflammatory caspases
initiates a cascade involving caspase-8 and -3 that is independent
of mitochondrial involvement [47,55]. However, in the Pt1 cells,
caspase-4 fails to initiate apoptosis most likely because of the
constant expression of Bcl-2 family members and as a default
undergo autophagy followed by necrotic cell death. Notably, there
is strong precedent for cells that are defective in both apoptosis and
autophagy to respond to stress by activating an inflammatory
program of gene expression and being shunted to a pathway of
necrotic cell death (reviewed in [41,56]). In particular, cells that
are both beclin and atg5 deficient are metabolically stressed and
activate autophagy as a means of increasing survivability [57].
Overall these results expand our understanding of the
relationship between c-Rel and LMP1, in particular how the co-
expression of these two genes affect B cell viability. In many cells,
reducing c-Rel expression would lead to arrested cell growth and
apoptosis via the loss of pro-survival gene expression. However, if
in fact the cell is associated with persistent LMP1 expression such
as in post-transplant proliferative disease (PTPD), Hodgkin’s
lymphoma or nasopharyngeal carcinoma, reducing c-Rel would
still lead to arrested proliferation but also lead to increased ER
stress and autophagy. The failure of autophagy to restore cellular
integrity would ultimately result in death by necrosis. Thus,
targeting c-Rel may in fact be sufficient to limit proliferation and
force EBV-associated tumors or -infected cells to engage an
autophagic program in response to metabolic stress that ultimately
leads to cell death by necrosis.
Materials and Methods
Antibodies and Cell Lines
The following polyclonal antibodies were obtained from Santa
Cruz Biotechnology: rabbit polyclonal anti-c-Rel, rabbit polyclon-
al anti-c-Myc, goat polyclonal anti caspase-4, rabbit polyclonal
anti-p65, goat polyclonal anti-p50, rabbit polyclonal anti-p52,
rabbit polyclonal anti-RelB, and goat polyclonal anti-actin. Rabbit
polyclonal anti-LC3 was a gift from Dr. Victor Jin, UMDNJ. Anti-
S6 mAb, rabbit polyclonal anti-caspase 4 and rabbit polyclonal
anti-phospho-CDC2 were purchased from Cell Signaling. Rabbit
anti-Bax and anti-Bak polyclonal antisera were obtained from
NeoMarkers. Mouse anti-Bcl-2 mAb, anti-Bcl-xL rabbit polyclon-
al anti-Mcl-1 rabbit polyclonal antisera were obtained from
Ancell, LabVision and Chemicon respectively. The mini-EBV
transformed (LCL
tet) primary B cells from Pt1 and control healthy
donors (C2 and D11) have been previously described [58]. These
lines were originally generated following appropriate written
consent and assent of the participants and with the approval of
the Institutional Review Board of Rutgers, The State University of
New Jersey. LCL
tet cell lines were maintained in RPMI-complete
(10% fetal bovine serum (FBS), 2% penicillin/streptomycin, 1%
L-glutamine, 1% sodium pyruvate and 16 non-essential amino
acids) supplemented with 1 mg/mL tetracycline (Tc) or soluble
CD40L (sCD40L) at a concentration of 500 ng/mL (Peprotec) for
indicated time periods.
Preparation of Total cell extract and immunoblotting
Cells were collected and washed with phosphate-buffered saline
(PBS) and then sedimented by centrifugation at 1200 rpm for
5 min. The cell pellet was resuspended in RIPA buffer (150 mM
NaCl, 1% NP-40, 50 mM Tris-Cl pH7.5, 5 mM EDTA.
0.1%SDS, 1 mM PMSF, 16Protease inhibitor cocktail (Roche),
1 mM Sodium ortho-vanadate and 5 mM NaFl) and incubated
15 min on ice with vigorous mixing. The extract was centrifuged
at 13,000 rpm at 4uC for 10 min. Supernatant was collected and
stored at 280uC until use. Immunoblotting was carried out exactly
as previously described [32].
RNA isolation and Real Time quantitative PCR
Total RNA was isolated using TRIZOL (Invitrogen). DNAse1
treated RNA was cleaned using the RNAEasy kit (Qiagen)
following the manufacturer’s instructions and 1 mg of RNA was
used to synthesize cDNA. Quantitative PCR was performed using
a StepOne Real Time PCR machine (Applied Biosystems) using
buffer and conditions suggested by the manufacturer. Select
primer sequences are listed in Table S1 and all other primers are
available upon request.
PCR amplification for human actin was performed on each
sample as a control. Relative differences between samples were
determined by calculating DDCT (Applied Biosystems). The
DDCT values were converted to fold differences compared with
control by raising 2 to the -DDCT power (2-DDCT).
Table 2. Identified pathways and associated genes
differentially expressed in pt1-LCL
tet cells
1.
ER/metabolic stress Function Fold change
IEX-1 (IER3) NF-kB regulator q4.5
HSPA6 Protein folding-heat shock q2.3
HSPA7 Protein folding-heat shock q2.0
Caspase-4 Cysteine protease q1.4
SDF2L1 O-Mannosylation q1.6
XBP1 Transcription factor q1.6
PDIA6 Isomerase q1.8
ATF5 Transcription factor q2.5
P62 (SQSTM1) Signaling adaptor q1.6
PTP1B Phosphatase q1.4
Autophagy
DRAM Lysosomal protein Q1.6
ATG3 Protein ubiquitination N. C.
ATG7 Protein ubiquitination N. C.
ATG4A Protease N. C.
ATG4B Protease N. C.
GABARAP (ATG8A) Receptor Binding protein N. C.
Inflammation
MMP7 Metalloproteinase q83.0
IL1B Cytokine q7.8
IL1BR Cytokine receptor q6.7
Stat3 Transcription Factor q1.9
CD28 Co-stimulatory receptor q2.3
CD19 Co-stimulatory receptor q3.5
CCL5 Chemokine q1.6
CCR7 Chemokine receptor q2.4
1IPA on genes that were differentially expressed by a minimum of 1.4-fold.
These represent only a subset of total identified genes. Arrows indicate
positive and negative fold increases and N. C. indicates ‘‘no change’’.
doi:10.1371/journal.pone.0025467.t002
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To assess cell growth in the population, Pt1 and control cells were
purified over ficoll to remove non-viable cells and 4610
6 cells were
plated in Tc media. At day 1, 3 and 6 cells were again purified over
ficoll and viable cells were counted following incubation with Trypan
Blue. To analyze proliferation, 1610
6 viable (Trypan-blue negative)
cells were washed and resuspended in PBS+0.1%BSA and incubated
for 10 min at RT with 5 mM 5, 6 carboxyfluoroscein diacetate
succinimidyl ester (CFSE) (Molecular Probes). After incubation, the
cell suspension was brought to 2% FBS and further incubated at
Figure 5. Caspase-4 is upregulated in Pt1 cells. (A) QRT-PCR analysis of caspase-4 expression in Pt1 and D11 control- LCL
tet cells. Numbers
shown are the mean and SEM of three independent experiments (* indicates a p#0.05) (B) Intra-cellular staining and flow cytometry analysis of total
caspase-4 expression in 2610
5 Pt1 and D11 control-LCL
tet cells. (C) Western blot analysis showing the expression of the pro-caspase and active
caspase-4 in 30 mg of total cell extract from Pt1 and D11 control LCL
tet cells. Actin is shown as a loading control. (D) Analysis of caspase 3 and 7 in
control D11 (left) and Pt1 cells (right) following incubation with flica-specific for the active sites of these caspases. Histograms are representative of
three independent experiments.
doi:10.1371/journal.pone.0025467.g005
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plated in a 1 ml final volume of RPMI-complete in the presence or
absence of Tc or in the absence of Tc plus 500 ng/mL sCD40L.
Stimulated cells were incubated at 37uC for up to 6 days. Cells were
collected at different time points, fixed in PBS+4% para-formalde-
hyde and analyzed by flow cytometry.
Intracellular Staining
Intracellular staining was performed using the eBioscience Intra
cellular staining kit. Briefly, cells were incubated in fixing/
permeabilization buffer followed by incubation with primary
antibody. Cells were washed and then incubated with PE-
conjugated secondary antibody and analyzed by flow cytometry.
Figure 6. c-Rel is a negative regulator of caspase-4 in EBV lymphoblastoid cells. (A) Intra-cellular staining and flow cytometry analysis of
total caspase-4 expression in 1610
6 Pt1-LCL
tet cells 48 h after cells were transiently transfected with either 20 mg of pJD-hc-Rel (open peak) or empty
vector (dark grey peak). Histograms are representative of three independent experiments. (B) Analysis of caspase-4 expression in D11 control cells
48 h after cells were transiently transfected with 1.3 mM siREL (open peak) or control sequence (dark grey peak). In both panels, the isotype control is
shown as a light grey peak. (C) QRT-PCR of HspA6 and HspA7 in cDNA generated from control C2-, D11- and Pt1-LCL
tet cells grown in Tc media.
Control levels were averaged and set to ‘‘1’’. (D) QRT-PCR of cDNA generated from Pt1-LCL
tet cells 48 h after transient transfection with 20 mg of pJD-
hc-Rel. Results are the average of three independent experiments and show the change in expression relative to the cells transfected with a control
vector (* indicates a p#0.05; ** indicates a p#0.01).
doi:10.1371/journal.pone.0025467.g006
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2.0610
5 Pt1 or control-LCL
tet cells were treated with 5 mM
QV-D-OPh (Calbiochem), 10 mM Z-LEVD-fmk (BioVision) or
with DMSO for 24 h and analyzed for cell death using the
Annexin-V apoptosis detection Kit (Santa Cruz) following
manufacturer’s instructions. For autophagy inhibition, 2.0610
5
Pt1 cells were treated with 10 mM 3-Methyladenine (3-MA)
(Fluka) or DMSO for 12 h and analyzed for cell death as
previously described. Caspase activity was analyzed using the
Policaspase Red FLICA kit (Immunochemistry Technologies).
Briefly, 2.0610
5 Pt1- or control-LCL
tet cells were treated with
Sulforhodamine FLICA for 2 h at 37uC as per manufacturer’s
instructions and analyzed by flow cytometry.
Transmission Electron Microscopy (TEM)
Pt1- or D11-LCL
tet cells grown in Tc media and centrifuged at
low speed to retrieve only live cells were fixed in Karnovsky’s
fixative (formaldehyde, 4% v/v and glutaraldehyde, 1% v/v, in
0.1 M Millonig’s phosphate buffer, pH 7.3) for 3 h and incubated
in 1% osmium tetroxide for 1 h followed by dehydration in a
graded ethanol series. Cells were embedded in Spurr’s embedding
media (Electron Microscopy Sciences) and sectioned with a
diamond knife (Ultracut E ultramicrotome; AO Reichert, Austria).
Thin sections were stained with a 5% (w/v) uranyl acetate solution
in 50% EtOH for 15 min followed by a 0.5% (w/v) lead citrate
solution in CO2-free, double-distilled water for 2 min. Electron
micrographs were taken using a model JEM 100 CX transmission
electron microscope (JEOL).
Array data analysis
Gene expression analysis was carried out at the Sanford-
Burnham Medical Research Institute’s Bioinformatics Shared
Resource facility. Total RNA samples were prepared in Trizol
from Pt1 and control cells grown in Tc media and centrifuged at
low speed to pellet only live cells. Analysis was carried out on a
human-HT Beadchip Array (48K probes) using an Illumina
Platform. Data were collected, and the initial analysis was
performed using GeneSpring GX11 software (Agilent). Only the
statistically significant data (p,0.05) were analyzed further.
Pathway clustering of genes showing greater than a 1.4-fold
difference between Pt1 and controls was carried out using
Ingenuity Pathway Analysis (IPA).
c-Rel Transfection
20 mg of plasmid pJDCMV19SVhc-Rel (pJD-hc-Rel) (a gift
from C. Gelinas (UMDNJ)), pJDCMV19SVhc-empty or 2 mgo f
pMaxGFP to calculate transfection efficiency were transfected into
between 1610
6 and 3610
6 Pt1-LCL
tet cells [58] using the Amaxa
Nucleofactor Transfection System (Lonza) (Solution V, program
X-001). 48 h post-transfection a percentage of the cells were
harvested and analyzed for expression of caspase 4 by flow
cytometry. The remaining cells were collected and total RNA was
isolated and used to generate cDNA for quantitative real-time
PCR analysis of multiple genes. Transfection efficiency was
between 45% and 55% for each experiment.
siRNA transfection
c-Rel or control siRNA (Santa Cruz) at a final concentration of
1.3 mM were transfected into control-LCL
tet cells using the
Amaxa Nucleofactor Transfection System (Lonza) (Solution V,
program X-001). 48 h post-transfection, cells were harvested and
analyzed for caspase-4 expression by flow cytometry.
Statistics
Mean with SE was calculated and data analyzed with Student
paired and unpaired t tests to determine statistical significance of
differences. Statistical analyses were performed using GraphPad
Prism (GraphPad Software). Values of p,0.05 were accepted as
statistically significant.
Supporting Information
Figure S1 Increased cell death in Pt1 cells does not
correspond to enhanced PARP, or Caspase 3 cleavage.
30 mg of total extracts from controls C2-, D11- and Pt1-LCL
tet
cells grown either in the presence or absence of Tc were analyzed
for the expression of (A) PARP, (B) the pro-and active forms of
caspase 3 and (C) proapoptotic proteins Bax and Bad.
(TIF)
Table S1 Primer Sequences used in qRT-PCR analysis.
(DOC)
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